DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS

This publication has 6 references indexed in Scilit:

• Cardiogenic Shock
  New England Journal of Medicine, 1994
• Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
  Journal of Medicinal Chemistry, 1993
• Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets
  Blood, 1987
• The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
  Proceedings of the National Academy of Sciences, 1985
• Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin
  Blood, 1985
• Speculations on the design of nonpeptidic peptidomimetics
  Trends in Pharmacological Sciences, 1982